تحليلات المنتج الاختيارية
بإذنك، نستخدم تحليلات محدودة تراعي الخصوصية لفهم مسارات البحث الفعالة. لا نستخدم أدوات تتبع إعلانية أو تسجيل الجلسات. يمكنك تغيير هذا الخيار في التفضيلات. اقرأ سياسة الخصوصية.
Samsung Electronics Co., Ltd. GDR (Preferred Stock)'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $281.6B | |
|---|---|---|
| P/E (forward) | 1.0x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | Trend |
|---|---|---|---|---|---|
| Period | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $302,231.36B | $258,935.49B | $300,870.90B | $333,605.94B | +3.3% |
| Gross profit | $112,189.59B | $78,546.91B | $114,308.64B | $131,370.43B | +5.4% |
| Operating income | $47,203.49B | $11,936.52B | $38,433.65B | $50,087.25B | +2.0% |
| Net income | $54,730.02B | $14,473.40B | $33,621.36B | $44,260.96B | -6.8% |
| EPS (diluted) | $201,425.00 | $53,275.00 | $123,750.00 | $165,075.00 | -6.4% |
| EBITDA | $86,311.15B | $50,603.08B | $81,064.47B | $97,013.85B | +4.0% |
| R&D | $24,919.20B | $28,339.72B | $34,998.14B | $37,740.39B | +14.8% |
| SG&A | $33,560.96B | $32,678.16B | $35,078.24B | $37,849.25B | +4.1% |
Recent company headlines from major financial publishers.
The bull case requires Samsung to successfully close the HBM technology gap with SK Hynix within an 18–24 month window — a specific, time-bounded catalyst that either materializes or doesn't. Our $2,628 bull case target is derived from FY2030 EPS of $220/GDR at 18x terminal P/E discounted back at quality Ke of 8.55% over five years. The 15% bull probability reflects the current state of evidence: Samsung has acknowledged HBM3E yield improvements in management commentary, is pursuing AMD qualification, and has the technological and financial capacity to close the gap — but has not yet produced the supply agreement evidence that would elevate probability toward 25–30%. The bull scenario is not a pure optimism exercise; it is grounded in Samsung's $37.7T R&D investment and the genuine technical capability demonstrated in its first-generation HBM products. If the primary catalyst materializes — NVIDIA confirmed supply agreement by Q4 2026 — the chain reaction through Samsung's financials is powerful and rapid. DS segment margins would expand from ~13% toward 20%+ as HBM premium pricing replaces standard DRAM commodity pricing in the product mix. This drives net income from the FY2025 recovery of KRW 44.3T toward KRW 60T+ by FY2027 and generates the EPS trajectory required for $220/GDR in FY2030. The market re-rating from 9.6x to 18x trailing P/E would represent Samsung achieving parity with Micron's current valuation (which trades at 24.8x trailing P/E) — a reasonable target for a company that has demonstrated HBM technology leadership.
The base case is a steady semiconductor cycle recovery where Samsung participates in the AI memory demand wave without emerging as the clear technology winner. HBM progress is real but measured — SK Hynix maintains market leadership, and Samsung's DS segment margin recovery is gradual rather than step-changed. Our base case target of $1,327 is derived from the probability-weighted forward earnings model: 50% base weight on FY2030 EPS of $145/GDR at 14x terminal P/E, discounted at moderate Ke of 8.90% over five years. The 24% total return from current levels over the five-year holding period represents a positive but modest real return — approximately 4.4% annualized before dividends (adding the ~1.07% dividend yield brings total return to approximately 5.5% annualized). The base case's primary limitation is its dependence on the memory cycle remaining constructive through FY2027. The base case also assumes that Samsung's current HBM market share of ~20% stabilizes rather than erodes, which requires continued R&D execution at the current $37.7T annual level and no further yield-related setbacks. The $1,327 base case target is broadly consistent with a GDR re-rating from 9.6x to approximately 10–11x forward P/E on FY2026E EPS of $134.65/GDR, which is a conservative multiple expansion relative to the potential re-rating if HBM market share inflects positively.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 8.05% | $2,108 | $2,228 | $2,386 | $2,567 | $2,767 |
| 8.30% | $2,000 | $2,106 | $2,232 | $2,383 | $2,571 |
| 8.55% | $1,906 | $2,013 | $2,127 | $2,265 | $2,417 |
| 8.80% | $1,823 | $1,909 | $2,011 | $2,133 | $2,279 |
| 9.05% | $1,742 | $1,820 | $1,922 | $2,033 | $2,165 |
Upcoming earnings date and setup when available.
التصنيف الذي حملته نسخة البحث المنشورة في كل شهر. يقارن التصنيف السعر في تاريخ التحليل بالقيمة العادلة، وليس سجلاً لمدى صحة التقدير.
| السنة | يناير | فبراير | مارس | أبريل | مايو | يونيو | يوليو | أغسطس | سبتمبر | أكتوبر | نوفمبر | ديسمبر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |